phenobarbital sodium msds - An Overview
phenobarbital sodium msds - An Overview
Blog Article
pentobarbital improves levels of vortioxetine by raising metabolism. Modify Therapy/Keep an eye on Carefully. Consider growing the vortioxetine dose when coadministered with potent CYP inducers for >fourteen days; to not exceed 3 times primary vortioxetine dose.
pentobarbital will decrease the level or effect of ibuprofen by affecting hepatic enzyme CYP2C9/10 metabolism. Small/Importance Unknown.
Keep track of Intently (1)pentobarbital will reduce the extent or effect of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. CYP3A4 inducers haven't been studied, coadministration not proposed by company
pentobarbital will lessen the extent or effect of fedratinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Effect of coadministering a robust CYP3A4 inducer with fedratinib has not been analyzed.
CONTRAINDICATIONS Barbiturates are contraindicated in individuals with known barbiturate sensitivity. Barbiturates will also be contraindicated in sufferers with a record of manifest or latent porphyria.
pentobarbital will lessen the level or effect of repaglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will minimize the extent or effect of abiraterone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the level or effect of fostemsavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will enhance the level or effect of clopidogrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lower the extent or effect of trazodone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will minimize the level or effect of celecoxib by impacting hepatic enzyme CYP2C9/ten metabolism. Minimal/Significance Unfamiliar.
pentobarbital will lessen the extent or effect of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.
pentobarbital will decrease the level or effect of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Loss of, or lessened reaction to tofacitinib could come about when coadministered with potent CYP3A4 inducers
pentobarbital will decrease the extent or effect website of alfuzosin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified.